advertisement
Pharmaceutics 33
Showing records 1 to 25 | Display all abstracts in Pharmaceutics95290 Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage
Zhang X
Pharmaceutics 2021; 13:
95515 The Effect of a Triple Combination of Bevacizumab, Sodium Hyaluronate and a Collagen Matrix Implant in a Trabeculectomy Animal Model
Andrés-Guerrero V
Pharmaceutics 2021; 13:
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Hsueh HT
Pharmaceutics 2021; 13:
94855 Distribution of Gold Nanoparticles in the Anterior Chamber of the Eye after Intracameral Injection for Glaucoma Therapy
Sonntag T; Froemel F
Pharmaceutics 2021; 13:
95515 The Effect of a Triple Combination of Bevacizumab, Sodium Hyaluronate and a Collagen Matrix Implant in a Trabeculectomy Animal Model
Camacho-Bosca I
Pharmaceutics 2021; 13:
95290 Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage
Zhang N
Pharmaceutics 2021; 13:
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Kim YC; Pitha I
Pharmaceutics 2021; 13:
95290 Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage
Chrenek MA
Pharmaceutics 2021; 13:
95515 The Effect of a Triple Combination of Bevacizumab, Sodium Hyaluronate and a Collagen Matrix Implant in a Trabeculectomy Animal Model
Salazar-Quiñones L
Pharmaceutics 2021; 13:
94855 Distribution of Gold Nanoparticles in the Anterior Chamber of the Eye after Intracameral Injection for Glaucoma Therapy
Stamer WD; Ohlmann A
Pharmaceutics 2021; 13:
95515 The Effect of a Triple Combination of Bevacizumab, Sodium Hyaluronate and a Collagen Matrix Implant in a Trabeculectomy Animal Model
Ventura-Abreu N
Pharmaceutics 2021; 13:
95290 Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage
Girardot PE
Pharmaceutics 2021; 13:
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Shin MD
Pharmaceutics 2021; 13:
95515 The Effect of a Triple Combination of Bevacizumab, Sodium Hyaluronate and a Collagen Matrix Implant in a Trabeculectomy Animal Model
Ventura-Abreu N
Pharmaceutics 2021; 13:
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Berlinicke CA
Pharmaceutics 2021; 13:
94855 Distribution of Gold Nanoparticles in the Anterior Chamber of the Eye after Intracameral Injection for Glaucoma Therapy
Fuchshofer R
Pharmaceutics 2021; 13:
95515 The Effect of a Triple Combination of Bevacizumab, Sodium Hyaluronate and a Collagen Matrix Implant in a Trabeculectomy Animal Model
Molero-Senosiain M
Pharmaceutics 2021; 13:
95290 Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage
Wang J; Sellers JT
Pharmaceutics 2021; 13:
94855 Distribution of Gold Nanoparticles in the Anterior Chamber of the Eye after Intracameral Injection for Glaucoma Therapy
Breunig M
Pharmaceutics 2021; 13:
95515 The Effect of a Triple Combination of Bevacizumab, Sodium Hyaluronate and a Collagen Matrix Implant in a Trabeculectomy Animal Model
Hernández-Ruiz S
Pharmaceutics 2021; 13:
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Chou RT; Kimball E; Kimball E
Pharmaceutics 2021; 13:
95515 The Effect of a Triple Combination of Bevacizumab, Sodium Hyaluronate and a Collagen Matrix Implant in a Trabeculectomy Animal Model
Bernal-Sancho G
Pharmaceutics 2021; 13:
95290 Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage
Geisert EE; Brenner C
Pharmaceutics 2021; 13:
95220 Ion-Complex Microcrystal Formulation Provides Sustained Delivery of a Multimodal Kinase Inhibitor from the Subconjunctival Space for Protection of Retinal Ganglion Cells
Schaub J
Pharmaceutics 2021; 13:
95515 The Effect of a Triple Combination of Bevacizumab, Sodium Hyaluronate and a Collagen Matrix Implant in a Trabeculectomy Animal Model
Herrero-Vanrell R
Pharmaceutics 2021; 13:
